Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine

Details Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine

2006-12-19

2006-12-19

Minnifield, Nita (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Parasitic organism or component thereof or substance...

C424S192100, C424S191100, C424S184100, C536S023100, C536S023400, C435S069500, C435S069700

Reexamination Certificate

active

07150875

ABSTRACT:
In this application is the expression and purification of a recombinantPlasmodium vivax(SalI) PvMSP-1 p42. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant PvMSP-1 p42 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.

REFERENCES:
patent: WO 9730159 (1997-08-01), None
patent: WO 99/56755 (1999-11-01), None
Gasser et al 1999. American Journal of Tropical Medicine and Hygiene, (Sep. 1999) vol. 61, No. 3 SUPPL., pp. 492.
Holm et a1, 1 997. Molecular and Biochemical Parasitology, 89, p. 313-319.
Genton et al 2000, vaccine 18: 2504-2511.
Chang et al 1996 (Infec.Immun; 64 253-261).
Cooper, J. A. 1993, Parasitol. Today 9:50-54.
Chitarra et al 1999 Mol. Cell 3:457-464.
Ling, et al 1994. Parasite Immunol. 16:63-67.
Ling et al 1995 Parasite Immunol. 17:425-433.
Egan et al 1997. Infect. Immun. 65:3024-3031.
Sachdeva et al Infection and Immunity 2004, 72; 5775-5782.
Longacre, S. et al., 1994. Plasmodium vivax merozoite surface protein 1 C-terminal recombinant proteins in baculovirus. Molecular and Biochemical Parasitoloty, 64, p. 191-205.
Dutta, S. et al., 2001. Purification, characterization, and immunogenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed inEshcerichia coli.Infection and Immunity 69, p. 5464-5470.

Affiliated with

Also associated with

Rating

Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3694887